Special import / unlicensed
Framework for unlicensed imported medicines (wave 2), North East and Yorkshire NHS
Open · 30 days left United Kingdom · Medicines
| Buyer | Leeds Teaching Hospitals NHS Trust, for the North East and Yorkshire NHS Pharmaceutical Purchasing Consortium |
|---|---|
| Reference | C475795 (2026/S 000-096479) |
| Closing date | 30 November 2026, 12:00 UK time (the notice gives no time zone) |
| Products | Unlicensed imported medicines with no UK marketing authorisation, including over-labelled and translated products, for NHS bodies. Estimated GBP 36.1m excl. VAT. Runs May 2027 to Dec 2028, extendable to Dec 2029. |
| Notes | Clarification questions are due by 6 Nov 2026 at 12:00. Register and bid on the Atamis e-sourcing portal (health-family.force.com). Bidders need MHRA licences to import and distribute unlicensed medicines and must show GMP and GDP compliance. Award weighting: 60% price, 30% quality, 10% social value. |
PharmaTradz is not the buyer. Read the full tender documents and any addenda on the buyer's site before bidding; they always prevail over this summary.
Typical documents for a medicines tender
- Registration in the buyer's country, or the alternative the tender accepts (for example WHO prequalification)
- GMP certificate for the manufacturing site and a certificate of pharmaceutical product (CoPP)
- Certificates of analysis, samples, stability data and labelling in the required language
- Bid security, authorisation letters and price schedules in the buyer's format
Need a supplier for this tender?
Tell us the lots, strengths and quantities. We match registered, GMP-certified manufacturers and can help with tender documents.
Request supplier quotesNew tenders in United Kingdom
We email you when new tenders for this country are listed. Confirm first; unsubscribe any time.
Other open tenders
- Framework for high-tech homecare medicines services, North East and Yorkshire NHS (United Kingdom, 16 Nov)
- Supply of linezolid 600 mg injection (Hong Kong SAR, China, 2 Nov)
- Supply of medicines for opportunistic infections (Government of Kenya) (Kenya, 3 Nov)
- Nationwide supply and distribution of adalimumab (Argentina, 3 Nov)
- Supply of ropeginterferon alfa-2b prefilled pens (Brunei, 3 Nov)
- Supply of nintedanib and dalbavancin for Hospital Universitario de Fuenlabrada (Spain, 10 Nov)
